- Home
- COYA vs SEER Comparison
COYA vs SEER Comparison
Compare COYA & SEER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COYA | SEER |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 111.4M |
| IPO Year | 2022 | 2020 |
Fundamental Metrics
Financial Performance| Metric | COYA | SEER |
|---|---|---|
| Price | $4.47 | $1.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | 101.5K | ★ 395.0K |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.40 |
| EPS | ★ N/A | N/A |
| Revenue | $3,554,061.00 | ★ $16,578,000.00 |
| Revenue This Year | $69.95 | $2.14 |
| Revenue Next Year | N/A | $25.90 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 16.99 |
| 52 Week Low | $3.94 | $1.62 |
| 52 Week High | $7.75 | $2.41 |
Technical Indicators
Market Signals| Indicator | COYA | SEER |
|---|---|---|
| Relative Strength Index (RSI) | 41.31 | 44.66 |
| Support Level | $4.50 | $1.71 |
| Resistance Level | $5.21 | $1.97 |
| Average True Range (ATR) | 0.27 | 0.08 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 22.00 | 28.42 |
Price Performance
Historical ComparisonAbout COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.